Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study (SIERRA 75)

Fundación EPIC

Status: Completed

Conditions: Coronary Artery Disease; Ischemic Heart Disease

Treatments: Device: XIENCE Sierra

Study type: Observational

Funder types: Other

Identifiers

NCT03567733

SIERRA 75 EPIC-05

Details and patient eligibility

About

This prospective registry is intended to evaluate the safety and efficacy of the XIENCE Sierra stent.

Full description

This prospective registry is intended to analyze clinical outcomes in elderly patients treated with XIENCE Sierra stent and in pre-established subgroups (stable and unstable coronary artery disease).

Enrollment: 1,000 patients

Sex: All

Ages: 75+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age> 75 years.
• With indication of percutaneous revascularization.
• Presence of de novo coronary artery lesions located in a native coronary artery.
• Informed consent signed

Exclusion criteria

• Cardiogenic shock at the time of the PCI(Percutaneous Coronary Intervention)
• Cardiac arrest before the PCI
• Life expectancy of the patient under 1 year
• Participation in another study with a drug or device in clinical research
• Clinical decision that excludes the use of drug-eluting stents
• Confirmed allergy to aspirin and / or thienopyridines.

Trial design

1,000 participants in 1 patient group

Coronary Artery Disease

Description:

Drug- eluting Stent

Treatment:

Device: XIENCE Sierra